Publications by authors named "Hiroshi Takatsuna"

Claim this Profile
E
Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study.
Takuya Nikaido, Hiroshi Takatsuna, Shunsuke Tabata, Kazuhito Shiosakai, Taichi Nakatani

Pain Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study.
Takuya Nikaido, Hiroshi Takatsuna, Shunsuke Tabata, Kazuhito Shiosakai, Taichi Nakatani

Pain Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirogabalin treatment of postoperative neuropathic pain after thoracic surgery: study protocol for a multicenter, randomized, open-label, parallel-group, interventional trial.
Ryoichiro Doi, Takuro Miyazaki, Tomoshi Tsuchiya, Keitaro Matsumoto, Koichi Tomoshige, Hiroshi Takatsuna

J Thorac Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cross-Sectional Web Survey of Satisfaction with Treatment for Pain in Participants with Suspected Diabetic Peripheral Neuropathic Pain in Both Feet.
Takahisa Deguchi, Hiroshi Takatsuna, Mizuka Yokoyama, Kazuhito Shiosakai, Teruyoshi Inoue

Adv Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study).
Yoshiyuki Kimura, Shigeki Yamaguchi, Takahiro Suzuki, Jitsu Kato, Satoko Chiba, Hiroshi Takatsuna

Pain Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cross-sectional Survey of Patients with Suspected Diabetic Peripheral Neuropathic Pain in Japan.
Hideyuki Sasaki, Hiroshi Takatsuna, Teruyoshi Inoue, Daiju Matsui, Hiroshi Sakoda

Intern Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study.
Masayuki Baba, Hiroshi Takatsuna, Norimitsu Matsui, Shoichi Ohwada

J Pain Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent prescription status of oral analgesics in Japan in real-world clinical settings: retrospective study using a large-scale prescription database.
Takahiro Ushida, Daiju Matsui, Teruyoshi Inoue, Mizuka Yokoyama, Hiroshi Takatsuna

Expert Opin Pharmacother· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Hiroshi Takatsuna, Masataka Asagiri, Takeshi Kubota, Kotaro Oka, Toshihiro Osada

J Bone Miner Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of bioactive metabolites for pancreatic regeneration chemotherapy.
Hiroshi Takatsuna, Kazuo Umezawa

Biomed Pharmacother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling.
Hiroshi Takatsuna, Hiroki Kato, Jin Gohda, Taishin Akiyama, Ayaka Moriya

J Biol Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis